Literature DB >> 28361366

A rare invasive hemangioma in cauda equina.

Hongfei Xiang1, Nana Shen2, Bohua Chen3, Xuexiao Ma4, Gang Xin5.   

Abstract

PURPOSE: Typical hemangioma of cauda equina with relative clear margin has been described in some case reports, but atypical hemangioma with invasion, infiltration, and augmentation of all nerve roots in the cauda equina area has never been reported. In this paper, we reported a rare case with invasive hemangioma in cauda equina, and analyzed its radiological appearance and treatment.
METHODS: We described an atypical case of hemangioma, which was revealed by MR and intraoperative photograph without clear margin and confirmed by histopathologic diagnosis.
RESULTS: The patient was received radiotherapy (5400 cGy/25f/5w) and continued to be clinically in good condition with follow-up MR after 24 months without further surgery.
CONCLUSIONS: Surgery may be the first management modality for hemangiomas with severe or progressive neurologic deficits, and radiotherapy may be an alternative therapy to treat hemangiomas according to accurate histopathologic diagnosis.

Entities:  

Keywords:  Cauda equina; Hemangioma; Radiotherapy

Mesh:

Year:  2017        PMID: 28361366     DOI: 10.1007/s00586-017-5028-4

Source DB:  PubMed          Journal:  Eur Spine J        ISSN: 0940-6719            Impact factor:   3.134


  14 in total

Review 1.  Imaging of spine neoplasm.

Authors:  John T Wald
Journal:  Radiol Clin North Am       Date:  2012-07       Impact factor: 2.303

Review 2.  Imaging of spinal and spinal cord tumors.

Authors:  J Keith Smith; Kenneth Lury; Mauricio Castillo
Journal:  Semin Roentgenol       Date:  2006-10       Impact factor: 0.800

Review 3.  Spinal intradural capillary haemangioma: a review.

Authors:  D A Nowak; D C Widenka
Journal:  Eur Spine J       Date:  2001-12       Impact factor: 3.134

4.  MRI of paraganglioma of the filum terminale.

Authors:  M P Boncoeur-Martel; A Lesort; J J Moreau; F Labrousse; I Roche; P Bouillet; J L Pascaud; J P Dupuy
Journal:  J Comput Assist Tomogr       Date:  1996 Jan-Feb       Impact factor: 1.826

Review 5.  Cauda equina paraganglioma: a review.

Authors:  George C Miliaras; Athanassios P Kyritsis; Konstantinos S Polyzoidis
Journal:  J Neurooncol       Date:  2003-11       Impact factor: 4.130

Review 6.  Radiotherapy for symptomatic vertebral hemangiomas: results of a multicenter study and literature review.

Authors:  Reinhard Heyd; M Heinrich Seegenschmiedt; Dirk Rades; Cornelia Winkler; Hans T Eich; Frank Bruns; Georg Gosheger; Normann Willich; Oliver Micke
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-08-21       Impact factor: 7.038

Review 7.  Spinal lipomas: clinical spectrum, embryology, and treatment.

Authors:  Michael A Finn; Marion L Walker
Journal:  Neurosurg Focus       Date:  2007       Impact factor: 4.047

8.  Spinal radiosurgical treatment for thoracic epidural cavernous hemangioma presenting as radiculomyelopathy: technical case report.

Authors:  Moon-Jun Sohn; Dong-Joon Lee; Sang-Ryong Jeon; Shin Kwang Khang
Journal:  Neurosurgery       Date:  2009-06       Impact factor: 4.654

Review 9.  Proximal nerve root spinal hemangioblastomas: presentation of three cases, MR appearance, and literature review.

Authors:  Edward J Escott; B K Kleinschmidt-DeMasters; Kerry Brega; Kevin O Lillehei
Journal:  Surg Neurol       Date:  2004-03

Review 10.  Diagnosis and treatment of vertebral hemangiomas with neurologic deficit: a report of 29 cases and literature review.

Authors:  Liang Jiang; Xiao Guang Liu; Hui Shu Yuan; Shao Min Yang; Jie Li; Feng Wei; Chen Liu; Lei Dang; Zhong Jun Liu
Journal:  Spine J       Date:  2013-10-08       Impact factor: 4.166

View more
  1 in total

Review 1.  Epithelioid Hemangioma of the Thoracic Spine: A Case Report and Review of the Literature.

Authors:  Eijiro Okada; Morio Matsumoto; Mitsuhiro Nishida; Takahito Iga; Midori Morishita; Masaki Tezuka; Kiyoshi Mukai; Eisuke Kobayashi; Kota Watanabe
Journal:  J Spinal Cord Med       Date:  2017-10-25       Impact factor: 1.985

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.